HF Etiology and cardiac contractility modulation therapy.
Karapet V DavtyanIvan ChugunovArpi H TopchyanYury MareevNatalia MironovaElena GupaloSergey GolitsynEvgeny N M MikhaylovDmitry S LebedevMarianna VanderElena A LyasnikovaMaria Yu SitnikovaKhatuna MinjiaSvetlana GlemboOleg SukhorukovPublished in: BMC cardiovascular disorders (2024)
In this multicenter retrospective study, patients with non-ischemic HFrEF showed a significantly higher improvement in LVEF and LV reverse remodeling following CCM therapy device implantation. There was no significant association between HF etiology and survival in drug-resistant HFrEF patients following CCM therapy.